- 全部删除
- 您的购物车当前为空
KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions.
为众多的药物研发团队赋能,
让新药发现更简单!
KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 772 | In stock | |
5 mg | ¥ 2,320 | In stock | |
10 mg | ¥ 3,730 | In stock | |
25 mg | ¥ 5,910 | In stock | |
50 mg | ¥ 8,330 | In stock | |
100 mg | ¥ 11,200 | In stock | |
500 mg | ¥ 22,500 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 2,450 | In stock |
KPLH1130 相关产品
产品描述 | KPLH1130, a specific pyruvate dehydrogenase kinase (PDK) inhibitor, enhances glucose tolerance in mice fed a high-fat diet (HFD). It effectively hinders macrophage polarization and mitigates proinflammatory reactions. |
分子量 | 283.28 |
分子式 | C15H13N3O3 |
CAS No. | 906669-07-6 |
Smiles | Cc1ccc(cc1)-n1c(n[nH]c1=O)-c1ccc(O)cc1O |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 130 mg/mL (458.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容